LIVINGSTON, NJ / ACCESSWIRE / March 29, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 3, 2018 to discuss the Company’s financial results for the full year ending December 31, 2018, as well as the Company’s corporate progress and other developments. The Company also announced it plans to report its earnings results pre-market on Tuesday, April 2, 2019.
The conference call will be available on the Company’s website at www.milestonescientific.com, or via telephone by dialing toll free 888-394-8218 and entering the pass code 3612710. For those unable to participate at that time, a replay of the call will be archived on the company’s website or can be accessed by dialing 888-203-1112 and entering the pass code 3612710. The replay will be available for 90 days.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.
CONTACT:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020
SOURCE: Milestone Scientific, Inc.
View source version on accesswire.com:
https://www.accesswire.com/540475/Milestone-Scientific-Schedules-2018-Year-End-Earnings-Conference-Call
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call…
Seasoned financial leader brings experience at leading companies in healthcare and software as a service…
The DynamX BTK System for the treatment of BTK vessels impacted by CLTI broadens the…
Babson introduces BetterWay™ blood testing, which uses a pea-sized amount of blood collected from a…
Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business UnitVancouver,…
CLEARWATER, FL / ACCESSWIRE / March 21, 2024 / Narconon Suncoast is proud to join…